House FY 2024 Approps Bill Nixes US FDA Mifepristone REMS Changes, Cuts Funding

 
• By Derrick Gingery
House Appropriations Committee screenshot
The House Appropriations Committee moved a bill to the floor that would make a small cut to the FDA's non-user fee funding in FY 2024. • Source: Screenshot of House of Representatives broadcast

More from US FDA

More from Agency Leadership